We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.20 | 3.63% | 34.30 | 33.90 | 34.15 | 34.40 | 32.85 | 32.85 | 1,271,643 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 200.29 | 183.92M |
TIDMAPH
RNS Number : 7944N
Alliance Pharma PLC
28 October 2016
28 October 2016
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Share Options
Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that on 27(th) October 2016 it awarded the following options over ordinary shares of the Company to certain Directors.
Name Position Number Exercise Date of Percentage of Share price vesting of issued Options per Share ordinary Awarded share capital -------------- ------------ ---------- ----------- --------- ----------- Chief Andrew Financial October Franklin Officer 155,000 47.50 2018 0.033 -------------- ------------ ---------- ----------- --------- ----------- Chief Andrew Financial October Franklin Officer 400,000 47.50 2020 0.085 -------------- ------------ ---------- ----------- --------- ----------- Deputy Chief Peter Executive October Butterfield Officer 200,000 47.50 2018 0.042 -------------- ------------ ---------- ----------- --------- ----------- Deputy Chief Peter Executive October Butterfield Officer 1,000,000 47.50 2020 0.212 -------------- ------------ ---------- ----------- --------- -----------
The vesting of the awards that are scheduled to vest in October 2018 is subject to continued employment and the vesting of the awards that are scheduled to vest in October 2020 is subject to continued employment and the satisfaction of certain performance conditions.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief Executive Andrew Franklin, Chief Financial Officer Sarah Robinson, Company Secretary www.alliancepharma.co.uk + 44 (0) 20 7466 Buchanan 5000 Mark Court / Sophie Cowles / Jane Glover + 44 (0) 20 7260 Numis Securities Limited 1000 Nominated Adviser: Michael Meade / Freddie Barnfield Corporate Broking: James Black / Toby Adcock
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international specialty pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
1 Details of the person discharging managerial responsibilities / person closely associated --- -------------------------------------------------------------------------- a) Name 1. Andrew Franklin 2. Peter Butterfield --- ------------------------- ----------------------------------------------- 2 Reason for the notification --- -------------------------------------------------------------------------- a) Position/status 1. Chief Financial Officer 2. Deputy Chief Executive Officer --- ------------------------- ----------------------------------------------- b) Initial notification Initial /Amendment --- ------------------------- ----------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- -------------------------------------------------------------------------- a) Name Alliance Pharma plc --- ------------------------- ----------------------------------------------- b) LEI n/a --- ------------------------- ----------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- -------------------------------------------------------------------------- a) Description of Options to subscribe for the financial new ordinary shares of 1p instrument, type each of instrument ISIN: GB0031030819 Identification code --- ------------------------- ----------------------------------------------- b) Nature of the Grant of options transaction --- ------------------------- ----------------------------------------------- c) Price(s) and volume(s) Exercise Price(s) Volume(s) ------------------ ------------------------- 1. 47.5p per 1. 555,000 share 2. 47.5p 2. 1,200,000 per share ------------------ ------------------------- --- ------------------------- ----------------------------------------------- d) Aggregated information Total 1,755,000 options granted at a price of 47.5p per share - Aggregated volume - Price --- ------------------------- ----------------------------------------------- e) Date of the transaction 27 October 2016 --- ------------------------- ----------------------------------------------- f) Place of the transaction Outside of trading venue --- ------------------------- -----------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHAKFDKABDDCKB
(END) Dow Jones Newswires
October 28, 2016 12:13 ET (16:13 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions